Zimmer Biomet Holdings, Inc.
ZBH
$90.55
$0.340.38%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.57% | -42.87% | 53.10% | 15.84% | -25.85% |
| Total Depreciation and Amortization | 6.62% | 9.29% | 4.02% | 2.40% | 2.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.95% | 64.57% | 55.06% | -21.70% | 16.21% |
| Change in Net Operating Assets | 65.21% | 2,545.45% | -56.88% | -7.50% | -16.77% |
| Cash from Operations | 67.89% | -13.95% | 17.21% | 6.18% | -25.90% |
| Capital Expenditure | 23.92% | 27.03% | 42.41% | 35.50% | -5.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -56.86% | -- | -375.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.06% | -221.40% | -15.48% | -35.21% | -5,690.00% |
| Cash from Investing | 45.64% | -31.88% | 6.46% | -1.60% | -30.52% |
| Total Debt Issued | 2,397.29% | 47.32% | 503.45% | 169.23% | -66.67% |
| Total Debt Repaid | -- | -178.69% | -150.00% | -- | -- |
| Issuance of Common Stock | -70.39% | -97.41% | -10.14% | -73.71% | 56.67% |
| Repurchase of Common Stock | -102.29% | 82.40% | -- | -500.70% | 57.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.24% | 4.38% | 1.80% | 1.79% | 1.79% |
| Other Financing Activities | -261.48% | -44.00% | -525.00% | -67.35% | 7.53% |
| Cash from Financing | 1,248.50% | 4.30% | 48.01% | 16.00% | 75.76% |
| Foreign Exchange rate Adjustments | 222.81% | -344.59% | 377.78% | 43.10% | -296.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,867.54% | -135.28% | 639.49% | 360.58% | 49.89% |